Latest filing published 19 Aug 2026 for INSMED Inc, €550k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Melvin Md Sharoky discloses dealings in INSMED Inc to SEC (Form 4). We count 24 filings; the first trade dates from 12 January 2021 and the latest from 17 August 2026.
The open-market side counts 2 purchases for €530k alongside 4 sales for €6.2M. Netting one side against the other leaves €5.7M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants. So far in 2026, the count stands at no purchases and 1 sale.
The newest entry dates from 19 August 2026: an open-market sale of €550k, in INSMED Inc. The latest purchase dates back some time: it was published 1,250 days ago, on 17 May 2023. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations